You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 19, October 25, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Hypertension
 •Alert me on articles by topic

Today’s Agenda

We Must Focus on Achieving Favorable Levels of All Risk Factors Simultaneously

Arch Intern Med. 2004;164:2086-2087.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

As experience with control of earlier epidemics has taught us, prevention of mass disease requires a comprehensive national public health policy that is implemented effectively throughout the population. The United States was one of the first countries to develop public policy in response to adverse coronary heart disease and cardiovascular disease (CVD) trends in the 1950s and early 1960s. Under joint leadership, professional, voluntary, and public organizations developed statements and guidelines that identified all major coronary heart disease risk factors and pinpointed approaches to their prevention and control. The National High Blood Pressure Education Program, launched in 1972, emphasized that high blood pressure (BP) was a major unsolved—but addressable—mass public health problem in the United States.1 In time, based on the recognition that the relation of BP to CVD is continuous, graded, and strong over the whole BP range,2 the focus has widened from interest mainly in elevated BP levels . . . [Full Text of this Article]


AUTHOR INFORMATION
Martha L. Daviglus, MD, PhD; Kiang Liu, PhD


RELATED ARTICLES

Prevalence of Heart Disease and Stroke Risk Factors in Persons With Prehypertension in the United States, 1999-2000
Kurt J. Greenlund, Janet B. Croft, and George A. Mensah
Arch Intern Med. 2004;164(19):2113-2118.
ABSTRACT | FULL TEXT  

Effects of Prehypertension on Admissions and Deaths: A Simulation
Louise B. Russell, Elmira Valiyeva, and Jeffrey L. Carson
Arch Intern Med. 2004;164(19):2119-2124.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient
Ong
QJM 2005;98:599-614.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.